ConductScience.org, home

Paper37733366

Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer.

Darst BF and 36 others. JAMA Oncol, 2023. Cited by 41 papers, by iCite.

Cite this record

ConductScience Library. Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer. Papers, record 37733366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37733366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer.
PubMed
Journal
JAMA Oncol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
3.29
iCite
Revised in PubMed
2026-10-28
PubMed

Authors37

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Darst BFBurcu F
2Saunders EEd
3Dadaev TTokhir
4Sheng XXin
5Wan PPeggy
6Pooler LLoreall
7Xia LYLucy Y
8Chanock SStephen
9Berndt SISonja I
10Wang YYing
11Patel AVAlpa V
12Albanes DDemetrius
13Weinstein SJStephanie J
14Gnanapragasam VVincent
15Huff CChad
16Couch FJFergus J
17Wolk AAlicja
18Giles GGGraham G
19Nguyen-Dumont TTu
20Milne RLRoger L

Source PubMed

See all 37 authorsDownload CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Prostatic NeoplasmsMajor topic
Male
Humans
DNA Repair
BRCA1 Protein
Neoplasm Grading
Germ Cells
DNA-Binding Proteins

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
29017Cancer Research UKUnited KingdomPubMedPubMed
P50 CA180995NCI NIH HHSUnited StatesP50CA180995PubMedNIH RePORTER
R01 CA196931NCI NIH HHSUnited StatesR01CA196931PubMedNIH RePORTER
P01 CA228696NCI NIH HHSUnited StatesP01CA228696PubMedNIH RePORTER
R00 CA246063NCI NIH HHSUnited StatesR00CA246063PubMedNIH RePORTER
K99 CA246063NCI NIH HHSUnited StatesK99CA246063PubMedNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in37733349Rare Genetic Drivers of Lethal Prostate Cancer.https://conductscience.org/library/papers/37733349

Source PubMed

Download CSV of comments and corrections

References50

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127989354Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.Eur Urol2017https://conductscience.org/library/papers/27989354PubMed
227268795The Ensembl Variant Effect Predictor.Genome Biol2016https://conductscience.org/library/papers/27268795PubMed
321240275Mutations of the SLX4 gene in Fanconi anemia.Nat Genet2011https://conductscience.org/library/papers/21240275PubMed
415583422Analysis of candidate genes for prostate cancer.Hum Hered2004https://conductscience.org/library/papers/15583422PubMed
532832836Pathogenic Variants in Cancer Predisposition Genes and Prostate Cancer Risk in Men of African Ancestry.JCO Precis Oncol2020https://conductscience.org/library/papers/32832836PubMed
634863587Inherited TP53 Variants and Risk of Prostate Cancer.Eur Urol2022https://conductscience.org/library/papers/34863587PubMed
729915322Rare germline variants in DNA repair genes and the angiogenesis pathway predispose prostate cancer patients to develop metastatic disease.Br J Cancer2018https://conductscience.org/library/papers/29915322PubMed
820609468Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.Lancet2010https://conductscience.org/library/papers/20609468PubMed
930590007Inherited NBN Mutations and Prostate Cancer Risk and Survival.Cancer Res Treat2019https://conductscience.org/library/papers/30590007PubMed
1034254341Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort.Prostate2021https://conductscience.org/library/papers/34254341PubMed
1122266095PTEN in DNA damage repair.Cancer Lett2012https://conductscience.org/library/papers/22266095PubMed
1229429804Clinical Outcome of Prostate Cancer Patients with Germline DNA Repair Mutations: Retrospective Analysis from an International Study.Eur Urol2018https://conductscience.org/library/papers/29429804PubMed
1323263490Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.Nat Genet2013https://conductscience.org/library/papers/23263490PubMed
1432444794High-throughput functional evaluation of BRCA2 variants of unknown significance.Nat Commun2020https://conductscience.org/library/papers/32444794PubMed
1530777372Germline DNA Repair Gene Mutations in Young-onset Prostate Cancer Cases in the UK: Evidence for a More Extensive Genetic Panel.Eur Urol2019https://conductscience.org/library/papers/30777372PubMed
1611181991Human DNA repair genes.Science2001https://conductscience.org/library/papers/11181991PubMed
1719596235Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair.Cell2009https://conductscience.org/library/papers/19596235PubMed
1836509074NCCN GuidelinesĀ® Insights: Prostate Cancer, Version 1.2023.J Natl Compr Canc Netw2022https://conductscience.org/library/papers/36509074PubMed
1935079693DNA Repair Pathways and Their Association With Lethal Prostate Cancer in African American and European American Men.JNCI Cancer Spectr2022https://conductscience.org/library/papers/35079693PubMed
2024556621Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease.Br J Cancer2014https://conductscience.org/library/papers/24556621PubMed

See all 50 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
42565081Clinical Impact of Germline Pathogenic Variants in High-risk Prostate Cancer Treated with Radiotherapy.Eur Urol Open Sci2026https://conductscience.org/library/papers/42565081PubMed
42552394Germline genetic risk and prostate cancer-specific mortality in a population-based incident cohort.Prostate Cancer Prostatic Dis2025https://conductscience.org/library/papers/42552394PubMed
42527158Unified genetic risk score for prostate cancer enables improved risk stratification for clinical decision-making.J Med Genet2026https://conductscience.org/library/papers/42527158PubMed
42271441Association analysis of germline variants in GEN1 with a susceptibility to prostate cancer in Polish men.Hered Cancer Clin Pract2026https://conductscience.org/library/papers/42271441PubMed
42032305Polygenic risk score and 20-year prostate cancer-specific mortality and survival.Commun Med (Lond)2026https://conductscience.org/library/papers/42032305PubMed
42001130Developing a germline prostate cancer risk test incorporating rare and common variants, to inform clinical decisions: a route to precision oncology.Genome Med2026https://conductscience.org/library/papers/42001130PubMed
41561489Genetic Testing and Imaging in Men with Familial History or Genetic Predisposition of Prostate Cancer-Introducing the Prospective "ProFam-Risk" Study.Eur Urol Open Sci2026https://conductscience.org/library/papers/41561489PubMed
41423785Revisiting the impact of BRCA1 pathogenic variants on the aggressiveness of prostate cancer.JNCI Cancer Spectr2026https://conductscience.org/library/papers/41423785PubMed
41219045Integrating Pathogenic Variants, Polygenic Risk Score, and Family History for Prostate Cancer Risk Estimation in Men of African Ancestry.Eur Urol2026https://conductscience.org/library/papers/41219045PubMed
41151852Angiogenic Edge of ANGPT2: Genetic Variants Shape Prostate Cancer Prognosis on Androgen Deprivation Therapy.Cancer Genomics Proteomics2025https://conductscience.org/library/papers/41151852PubMed
41070818Management of individuals with heterozygous germline pathogenic variants in RAD51C, RAD51D, and BRIP1: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).Genet Med2025https://conductscience.org/library/papers/41070818PubMed
41038821Pathogenic variants reveal candidate genes for prostate cancer germline testing for men of African ancestry.Nat Commun2025https://conductscience.org/library/papers/41038821PubMed
40914252Exploring Molecular Characteristics and Therapeutic Strategies for Primary Sinonasal Mucosal Melanoma With Distant Metastasis.Lab Invest2025https://conductscience.org/library/papers/40914252PubMed
40805222Germline BARD1 Mutation in High-Risk Chinese Breast and Ovarian Cancer Patients.Cancers (Basel)2025https://conductscience.org/library/papers/40805222PubMed
40328961Predisposition to prostate cancer and clinical implications in a real-life cohort.Eur J Hum Genet2025https://conductscience.org/library/papers/40328961PubMed
40187970Identifying Patients at Risk of Early Lethal Prostate Cancer by Integrating Family History, Polygenic Risk Score, Rare Variants in DNA Repair Genes, and Lifestyle Factors.Eur Urol Oncol2026https://conductscience.org/library/papers/40187970PubMed
40046829UK-based clinical testing programme for somatic and germline BRCA1/2, ATM and CDK12 mutations in prostate cancer: first results.BMJ Oncol2025https://conductscience.org/library/papers/40046829PubMed
39971927Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases.Nat Commun2025https://conductscience.org/library/papers/39971927PubMed
39700441Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now.JCO Oncol Pract2025https://conductscience.org/library/papers/39700441PubMed
39666350Polygenic Risk Score and Upgrading in Patients With Prostate Cancer Receiving Active Surveillance.JAMA Oncol2025https://conductscience.org/library/papers/39666350PubMed

See all 27 cited byDownload CSV of cited by

Genes11

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37733366

GET https://conductscience.org/api/papers/v1/37733366/authors?page=2